Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Fanelli C et al. | 1999 | intact cell/cell culture, CEM cells (human acute lymphoblastic leukemia), U937 (human leukemic monocyte cell line), leucocytes, rat thymocytes | static magnetic field | 6 mT |
Tenuzzo B et al. | 2006 | intact cell/cell culture, human lymphocytes, mouse thymocytes, FRTL-5 cells (Fischer rat thyroid cells), Hep G2 cells (hepatic transformed cell line), HeLa cell line (human adenocarcinoma cell line), U937 (human leukemic monocyte cell line) and 3 DO cells (T cell hybridoma cell li | static magnetic field | 6 mT |
Ghibelli L et al. | 2006 | intact cell/cell culture, Jurkat cells (human lymphoblastoid T cells) and U937 (human leukemic monocyte cell line) | static magnetic field, MRI, therapeutic/medical device | 6 mT–1 T |
Piatti E et al. | 2002 | bacterium, <i>Serratia marcescens</i> | static magnetic field | 8 mT |
Stansell MJ et al. | 2001 | bacterium, <i>Escherichia coli</i> | static magnetic field | 8–60 mT |
Chen WF et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | static magnetic field, co-exposure | 8.8 mT |
Sun RG et al. | 2012 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | static magnetic field | 8.8 mT |
Abdolmaleki P et al. | 2007 | intact cell/cell culture, tobacco cell | static magnetic field, DC | 10–30 mT |
Bandara HM et al. | 2015 | bacterium, <i>Pseudomonas aeruginosa</i> | magnetic field, static magnetic field, intermediate frequency, co-exposure | 12–444 mT |
Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.